Acro Biomedical (ACBM) Other Non Operating Income (2025 - 2026)
Acro Biomedical (ACBM) posted Other Non Operating Income of -$3802.0 for Q2 2026, down 95.17% on a QoQ basis from -$1948.0 in Q2 2025, and down 95.17% year-over-year from -$78790.4 in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) Other Non Operating Income (2025 - 2026) Analysis & Trends
Acro Biomedical has reported Other Non Operating Income for 2 years, with the latest figure at -$3802.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - |